Oligodendroglioma is a type of tumor of the central nervous system that originates primarily from glial cells rather than nerve cells. It belongs to a group of gliomas that form from glial cells that support and protect nerve cells in the brain and spinal cord.
Oligodendroglioma usually grows slowly and can reside in the brain for many years without showing symptoms. However, when the tumor begins to grow, it can press on nearby areas of the brain, causing a variety of symptoms such as headaches, seizures, blurred vision, hearing or speech, and loss of coordination.
The exact causes of oligodendroglioma are unknown, but certain factors, such as heredity, age and environment, may increase the risk of developing it. The diagnosis is usually made after a computed tomography (CT) or magnetic resonance imaging (MRI) scan of the brain, as well as a biopsy, in which a sample of tumor tissue is removed for examination.
Treatment for oligodendroglioma may include surgical removal of the tumor, radiation therapy, and chemotherapy. The choice of method depends on many factors, such as the size and location of the tumor, its stage and the general condition of the patient. In some cases, when the tumor grows slowly and does not cause symptoms, observation and non-invasive treatment may be performed.
Overall, the prognosis for patients with oligodendroglioma depends on many factors, including the stage of the tumor, its location and size, as well as the age and general condition of the patient. With timely treatment and the right approach to treatment, many patients successfully cope with this tumor and lead full lives.
Oligodendroglioma is a tumor of the central nervous system that originates primarily from glial cells rather than nerve cells. This is a rare type of glioma that accounts for about 5-15% of all gliomas. The tumor gets its name from its ability to produce oligodendrocytes, glial cells that play an important role in supporting the nervous system.
Oligodendroglioma usually occurs in the white matter of the brain, although it can rarely occur in other parts of the central nervous system. It is more common in adults aged 40 to 60 years, but can also occur in children.
Oligodendroglioma can present with a variety of symptoms, depending on its location in the brain and the size of the tumor. It can cause headaches, seizures, loss of consciousness, blurred vision and speech, changes in behavior and memory, and other neurological symptoms.
To diagnose oligodendroglioma, various tests may be required, such as magnetic resonance imaging (MRI), computed tomography (CT), biopsy, and others. Treatment for the tumor may include surgical removal, radiation therapy, and chemotherapy. The choice of treatment depends on the type and grade of the tumor, its location and size.
Although oligodendroglioma is a rare type of tumor, it is a serious disease that can lead to serious consequences. Prompt identification and treatment of a tumor can significantly increase the chances of recovery and improve the patient's quality of life.
**Oligodendroglial tumors of the central nervous system (also known as oligodendogliomas)** occur in children and young adults. Consist of neurons and glial cells. Glial cells usually do not tolerate tumor surgery well, especially if it is located in areas where it is difficult to remove the tumor surgically
In children, surgical treatment may be easier. In addition, childhood oligodendrotic tumor is more sensitive to radiation therapy
Combination treatment is used as therapy for an adult patient. If the tumor is located near the ventricles of the brain, then radiation therapy is performed, but its effect is much weaker than with other types of tumors
Oligodendoglioma is a tumor consisting of glial cells in the central nervous system. The tumor arises from one or more glial cell populations—oligodendrocytes or squamous cells. Most oligodendogiomas are multifocal tumors, meaning there is more than one node in the brain and tumor foci in different areas of the brain. Such tumors occur in old age. Growth is faster and more rapid, the malignant scenario involves the early manifestation of invasive vessels and tumor foci. In men, malignancy occurs more often.